P. W. Wijermans

2.1k total citations
49 papers, 1.6k citations indexed

About

P. W. Wijermans is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, P. W. Wijermans has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 19 papers in Oncology and 13 papers in Genetics. Recurrent topics in P. W. Wijermans's work include Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (10 papers). P. W. Wijermans is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (11 papers) and Multiple Myeloma Research and Treatments (10 papers). P. W. Wijermans collaborates with scholars based in Netherlands, Belgium and Germany. P. W. Wijermans's co-authors include W.B.J. Gerrits, H. L. Haak, Frits R. Rosendaal, Hanneke C. Kluin‐Nelemans, Martin den Heijer, Gerard M.J. Bos, Henk J. Blom, Paul Neve, J. Hermans and E.M. Noordijk and has published in prestigious journals such as The Lancet, Blood and Journal of Clinical Epidemiology.

In The Last Decade

P. W. Wijermans

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. W. Wijermans Netherlands 18 792 438 330 323 304 49 1.6k
Henrik Gregersen Denmark 23 727 0.9× 395 0.9× 270 0.8× 499 1.5× 385 1.3× 70 1.7k
H. L. Haak Netherlands 17 1.1k 1.4× 283 0.6× 286 0.9× 320 1.0× 534 1.8× 42 1.8k
Elena Oldani Italy 18 570 0.7× 441 1.0× 332 1.0× 173 0.5× 236 0.8× 41 1.2k
Sergio Storti Italy 20 740 0.9× 419 1.0× 469 1.4× 235 0.7× 545 1.8× 72 1.7k
Piera Viero Italy 24 1.2k 1.5× 675 1.5× 438 1.3× 336 1.0× 737 2.4× 81 2.3k
David Sutton Canada 25 884 1.1× 424 1.0× 477 1.4× 269 0.8× 456 1.5× 57 2.2k
Marciano D. Reis Canada 22 431 0.5× 332 0.8× 369 1.1× 356 1.1× 340 1.1× 71 1.6k
Yeung‐Chul Mun South Korea 22 634 0.8× 647 1.5× 455 1.4× 422 1.3× 340 1.1× 149 1.8k
Zora Marjanovic France 22 475 0.6× 378 0.9× 907 2.7× 216 0.7× 227 0.7× 79 2.3k
Ming‐Chung Kuo Taiwan 20 686 0.9× 224 0.5× 301 0.9× 379 1.2× 361 1.2× 84 1.2k

Countries citing papers authored by P. W. Wijermans

Since Specialization
Citations

This map shows the geographic impact of P. W. Wijermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. W. Wijermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. W. Wijermans more than expected).

Fields of papers citing papers by P. W. Wijermans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. W. Wijermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. W. Wijermans. The network helps show where P. W. Wijermans may publish in the future.

Co-authorship network of co-authors of P. W. Wijermans

This figure shows the co-authorship network connecting the top 25 collaborators of P. W. Wijermans. A scholar is included among the top collaborators of P. W. Wijermans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. W. Wijermans. P. W. Wijermans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deschler-Baier, Barbara, Gabriele Ihorst, Ulrich Germing, et al.. (2012). Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica. 98(2). 208–216. 152 indexed citations
2.
Teng, Y K Onno, Emile F. Schippers, & P. W. Wijermans. (2011). Regression of HIV-associated grade IV T cell lymphoma with combined antiretroviral therapy only. International Journal of Hematology. 93(6). 811–814. 1 indexed citations
3.
Klaasen, Rolf Anton, et al.. (2007). Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy.. PubMed. 65(4). 147–9. 15 indexed citations
4.
Ypma, Paula F., P. W. Wijermans, Hille Koppen, & Peter A.E. Sillevis Smitt. (2006). Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma.. PubMed. 64(7). 243–7. 10 indexed citations
5.
Schaar, C. G., Hanneke C. Kluin‐Nelemans, Saskia le Cessie, et al.. (2005). Interferon-α as maintenance therapy in patients with multiple myeloma. Annals of Oncology. 16(4). 634–639. 41 indexed citations
6.
Imhoff, Gustaaf W. van, Bronno van der Holt, Marius MacKenzie, et al.. (2005). Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia. 19(6). 945–952. 30 indexed citations
7.
Vermeer, Henricus J., et al.. (2004). Exclusion of venous thromboembolism: evaluation of D-Dimer PLUS for the quantitative determination of D-dimer. Thrombosis Research. 115(5). 381–386. 15 indexed citations
8.
Lübbert, Michael, et al.. (2003). Acute myeloid leukemia of the elderly: results of induction after previous treatment of high-risk myelodysplastic syndrome with a demethylating agent. FreiDok plus (Universitätsbibliothek Freiburg). 1 indexed citations
9.
10.
11.
Maartense, E., Saskia le Cessie, Hanneke C. Kluin‐Nelemans, et al.. (2002). Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin’slymphoma registry. Annals of Oncology. 13(8). 1275–1284. 21 indexed citations
12.
Blok, P, et al.. (2002). Disappearance of a mucosa‐associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori. European Journal Of Haematology. 68(3). 187–188. 27 indexed citations
13.
14.
Ossenkoppele, GJ, Bronno van der Holt, LF Verdonck, et al.. (1998). A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group.. Data Archiving and Networked Services (DANS). 1 indexed citations
15.
Maartense, E., J. Hermans, Hanneke C. Kluin‐Nelemans, et al.. (1998). Elderly patients with non-Hodgkin’s lymphoma: Population-based results in the Netherlands. Annals of Oncology. 9(11). 1219–1227. 45 indexed citations
16.
Ong, F., J. Hermans, E.M. Noordijk, et al.. (1997). Developing a population-based registry for patients with paraproteinemias or multiple myeloma. Journal of Clinical Epidemiology. 50(8). 909–915. 7 indexed citations
17.
Ong, F., et al.. (1997). A population‐based registry on paraproteinaemia in the Netherlands. British Journal of Haematology. 99(4). 914–920. 27 indexed citations
18.
Tesselaar, Margot, et al.. (1996). [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].. PubMed. 140(38). 1900–2. 1 indexed citations
19.
Wijermans, P. W., et al.. (1992). Hyaline-Vascular Type Castleman’s Disease with Concomitant Malignant B-Cell Lymphoma. Acta Haematologica. 87(3). 160–162. 9 indexed citations
20.
Koeleman, Johannes G.M., et al.. (1990). Cryptococcal meningo-encephalitis after prolonged corticosteroid therapy.. PubMed. 36(5-6). 242–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henrik Gregersen Breakdown of academic impact, for papers by H. L. Haak Breakdown of academic impact, for papers by Elena Oldani Breakdown of academic impact, for papers by Sergio Storti Breakdown of academic impact, for papers by Piera Viero Breakdown of academic impact, for papers by David Sutton Breakdown of academic impact, for papers by Marciano D. Reis Breakdown of academic impact, for papers by Yeung‐Chul Mun Breakdown of academic impact, for papers by Zora Marjanovic Breakdown of academic impact, for papers by Ming‐Chung Kuo
Rankless by CCL
2026